Literature DB >> 6392401

Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.

E Schober, G Schernthaner, H Frisch, M Fink.   

Abstract

In 9 newly diagnosed type I diabetic children the residual beta-cell secretory capacity was examined after stimulation with oral glucose load, glucagon and iv glucose plus arginine hydrochloride administration shortly after diagnosis and in the partial remission phase. A significant C-peptide secretion induced by these substances except by iv glucose was found at both investigation times. Whereas beta-cell function did only slightly increase from the initial testing to the measurements in the partial remission, beta-cell sensitivity increased significantly (p less than 0.05). The data suggest that "partial remission" referred to C-peptide secretion starts very early after insulin treatment and that other factors, possibly a decrease of peripheral insulin resistance, are involved in the improved metabolic control in partial remission phase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392401     DOI: 10.1007/BF03348458

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment.

Authors:  O K Faber; C Binder
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

2.  Diabetes in remission. Insulin secretory dynamics.

Authors:  B N Park; R E Gleason; J S Soeldner
Journal:  Diabetes       Date:  1974-07       Impact factor: 9.461

3.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

4.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-10       Impact factor: 3.791

5.  C-peptide secretion during the remission phase of juvenile diabetes.

Authors:  E Heinze; W Beischer; L Keller; G Winkler; W M Teller; E F Pfeiffer
Journal:  Diabetes       Date:  1978-06       Impact factor: 9.461

6.  beta-cell function in children with diabetes.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

7.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

Authors:  J Mirouze; J L Selam; T C Pham; E Mendoza; A Orsetti
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

8.  Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery.

Authors:  M B Block; M E Mako; D F Steiner; A H Rubenstein
Journal:  J Clin Endocrinol Metab       Date:  1972-09       Impact factor: 5.958

9.  Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment.

Authors:  S Madsbad; T Krarup; L Regeur; O K Faber; C Binder
Journal:  Acta Endocrinol (Copenh)       Date:  1980-11

10.  Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction.

Authors:  S Srikanta; O P Ganda; R A Jackson; R E Gleason; A Kaldany; M R Garovoy; E L Milford; C B Carpenter; J S Soeldner; G S Eisenbarth
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

View more
  3 in total

1.  Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

Authors:  M Wallensteen; G Dahlquist; B Persson; M Landin-Olsson; A Lernmark; G Sundkvist; B Thalme
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

2.  Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.

Authors:  E B Sochett; D Daneman; C Clarson; R M Ehrlich
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

Review 3.  Anti-CD38 autoantibodies in type? diabetes.

Authors:  Roberto Mallone; Paolo Cavallo Perin
Journal:  Diabetes Metab Res Rev       Date:  2006 Jul-Aug       Impact factor: 4.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.